NFKB1 -94 insertion/deletion polymorphism and cancer risk: A meta-analysis

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5181-5187

  Xu, Linlin ^a   Huang, Shaoyi ^b   Chen, Wei ^c   Song, Zhichun ^d   Cai, Shu ^e  

^a Yancheng First People's Hospital   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d WENZHOU MEDICAL UNIVERSITY   (China)

^e Second People's Hospital   (China)

Author keywords

Meta analysis; NFKB1; Polymorphism cancer

Indexed keywords

ARTICLE; ASIAN; BLADDER CANCER; CANCER RISK; CAUCASIAN; COLORECTAL CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; HUMAN; INDEL MUTATION; LIVER CELL CARCINOMA; LUNG CANCER; MOUTH SQUAMOUS CELL CARCINOMA; NFKB1 GENE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK;

EID: 84904764420     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1672-z     Document Type: Article

References (32)

1. Yaghoobi M, Rakhshani N, Sadr F, Bijarchi R, Joshaghani Y, et al. Hereditary risk factors for the development of gastric cancer in younger patients. BMC Gastroenterol. 2004;4:28.
2. Berlau J, Glei M, Pool-Zobel BL. Colon cancer risk factors from nutrition. Anal Bioanal Chem. 2004;378:737-43. (Pubitemid 40877764)
3. Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V. Multifaceted link between cancer and inflammation. Biosci Rep. 2012;32:1-15.
4. Song L, Li J, Zhang D, Liu ZG, Ye J, Zhan Q, et al. IKKβ programs to turn on the GADD45α-MKK4-JNK apoptotic cascade specifically via p50 NFkB1 in arsenite response. J Cell Biol. 2006;175:607-17. (Pubitemid 44790614)
5. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109:81-96.
6. Solan NJ, Miyoshi H, Carmona EM, Bren GD, Paya CV. RelB cellular regulation and transcriptional activity are regulated by p100. J Biol Chem. 2002;277:1405-18. (Pubitemid 34968896)
7. Giefing M, Wierzbicka M, Rydzanicz M, Cegla R, Kujawski M, et al. Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors. Neoplasma. 2008;55:55-60.
8. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet. 2004;13:35-45. (Pubitemid 38072133)
9. Zhang P, Wei Q, Li X, Wang K, Zeng H, Bu H, et al. A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet. 2009;191:73-7.
10. Cheng CW, Su JL, Lin CW, Su CW, Shih CH, Yang SF, et al. Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features. PLoS One. 2013;8:e56130.
11. Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, Andee ZD, et al. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol. 2013;37:634-8.
12. Lo SS, Chen JH, Wu CW, Lui WY. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery. 2009;145:280-5.
13. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett. 2006;243:47-54.
14. Riemann K, Becker L, Struwe H, Nückel H, Dührsen U, Alakus H, et al. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B cell chronic lymphocytic leukemia. Pharmacogenet Genomics. 2006;16:783-8. (Pubitemid 44632292)
15. Lehnerdt GF, Bankfalvi A, Grehl S, Adamzik M, Lang S, Schmid KW, et al. No association of the NF-kappaB1 -94ins/delATTG promoter polymorphismwith relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck region. Int J Immunopathol Pharmacol. 2008;21:827-32.
16. Li P, Gu J, Yang X, Cai H, Tao J, Yang X, et al. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population. PLoS One. 2013;8:e71604.
17. Kopp TI, Friis S, Christensen J, Tjønneland A, Vogel U. Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men. Cancer Genet. 2013.pii: S2210-7762(13)00084-7
18. Huo ZH, Zhong HJ, Zhu YS, Xing B, Tang H. Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility. Genet Mol Res. 2013;12:3435-43.
19. Huang D, Yang L, Liu Y, Zhou Y, Guo Y, Pan M, et al. Functional polymorphisms in NFκB1/IκBα predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese. Hum Genet. 2013;132:451-60.
20. Vangsted AJ, Nielsen KR, Klausen TW, Haukaas E, Tjønneland A, Vogel U. A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma. Br J Haematol. 2012;158:515-8.
21. Lin CW, Hsieh YS, Hsin CH, Su CW, Lin CH, Wei LH, et al. Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS One. 2012;7:e35078.
22. Fan Y, Yu W, Ye P, Wang H, Wang Z, Meng Q, et al. NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population. DNA Cell Biol. 2011;30:241-5.
23. Zhou B, Qie M, Wang Y, Yan L, Zhang Z, Liang A, et al. Relationship between NFKB1-94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol. 2010;21:506-11.
24. Tang T, Cui S, Deng X, Gong Z, Jiang G, Wang P, et al. Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese. DNA Cell Biol. 2010;29:9-12.
25. Andersen V, Christensen J, Overvad K, Tjønneland A, Vogel U. Polymorphisms in NFkB, PXR. LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer. 2010;10:484.
26. Zhou B, Rao L, Li Y, Gao L, Wang Y, Chen Y, et al. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett. 2009;275:72-6.
27. He Y, Zhang H, Yin J, Xie J, Tan X, Liu S, et al. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis. 2009;30:1916-22.
28. Burnik FS, Yalçin S. NFKB1-94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors. Chemotherapy. 2009;55:381-5.
29. Riemann K, Becker L, Struwe H, Rübben H, Eisenhardt A, Siffert W. Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. Int J Clin Pharmacol Ther. 2007;45:423-30. (Pubitemid 47243938)
30. Zou YF, Yuan FL, Feng XL, Tao JH, Ding N, Pan FM, et al. Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis. Cancer Invest. 2011;29:78-85.
31. Lewander A, Butchi AK, Gao J, He LJ, Lindblom A, Arbman G, et al. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand J Gastroenterol. 2007;42:1332-8. (Pubitemid 47537062)
32. Bu H, Rosdahl I, Sun XF, Zhang H. Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features, and tumor progression in Swedish melanoma patients. J Cancer Res Clin Oncol. 2007;133:859-66. (Pubitemid 350218912)